Related Experiment Video
Updated: Dec 10, 2025
04:00
Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
Published on: July 26, 2024
989
Sarcopenia and Frailty in Chronic Liver Damage: Common and Different Points
Hiroki Nishikawa1,2, Kazunori Yoh3, Hirayuki Enomoto3
1Department of Internal Medicine, Division of Gastroenterology and Hepatology, Hyogo College of Medicine, Nishinomiya, Japan nishikawa_6392_0207@yahoo.co.jp.
In Vivo (Athens, Greece)
|September 3, 2020
Summary
Sarcopenia and frailty are distinct conditions in chronic liver damage (CLD), though both increase with age and cirrhosis. Separate evaluation is recommended for effective management of these age-related muscle conditions.
Area of Science:
- Gerontology and Geriatric Medicine
- Hepatology and Gastroenterology
- Muscle Physiology and Aging
Background:
- Chronic liver damage (CLD) is associated with significant physiological decline.
- Sarcopenia (muscle loss) and frailty (increased vulnerability) are common in aging populations and can be exacerbated by chronic diseases.
- Understanding the overlap and distinctions between sarcopenia and frailty in CLD is crucial for patient care.
Purpose of the Study:
- To differentiate between sarcopenia and frailty in patients with chronic liver damage.
- To identify commonalities and unique characteristics of sarcopenia and frailty in this cohort.
- To inform clinical evaluation and management strategies for individuals with CLD.
Main Methods:
- Sarcopenia was defined by reduced grip strength and skeletal muscle index.
- Frailty was assessed using a standardized criteria including exhaustion, weight loss, slow walking speed, muscle weakness, and low physical activity.
- Prevalence and associated factors were analyzed in patients with CLD.
Main Results:
- Sarcopenia affected 15.2% and frailty 13.5% of the CLD patient cohort.
- Prevalence of both conditions correlated with age and liver cirrhosis (LC) status.
- Multivariate analysis identified age, LC, BMI, and ECW/TBW ratio as factors for sarcopenia, while only ECW/TBW ratio was significant for frailty.
Conclusions:
- Sarcopenia and frailty represent distinct clinical entities in patients with chronic liver damage.
- The differing etiological factors underscore the need for separate diagnostic evaluations.
- Tailored management approaches are necessary for sarcopenia and frailty in the context of CLD.
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
103
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
103
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
129
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
129
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
377
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
377
01:29Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
01:24Chronic Kidney Disease II: Clinical Manifestations
415
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
415
01:30Liver Physiology
3.2K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
3.2K